Bariatric surgery for patients with morbid obesity results in greater improvements in weight loss and type 2 diabetes outcomes compared with nonsurgical interventions (1). However, individuals with prior morbid obesity who had bariatric surgery can have altered drug absorption, distribution, and metabolism (2). The cumulative effect of bariatric surgery on medication use patterns has not been systematically investigated to improve postsurgery patient care. Using National Health and Nutrition Examination Survey (NHANES) data from 2015 to 2018, we identified and compared medication use in adults who had bariatric surgery with their former peers who were morbidly obese but did not have bariatric surgery.
Patiëntvoorbeelden m.b.t. vergoeding
- ten laste van verzekeraar
- geen vergoeding door verzekeraar